A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)
A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)
This study aims to assess the safety, tolerability and efficacy of Doxazosin GITS in Filipino
 patients diagnosed with Benign Prostatic Hyperplasia (BPH) under the usual clinical care
 setting.
This is an open label study. All patients prescribed with Doxazosin GITS can be enrolled in
 this study.
Inclusion Criteria:

 -  Subjects that will be included must be consistent with the approved label indication
 of Doxazosin mesylate GITS in the Philippines, which includes adult male diagnosed
 with BPH, and who are prescribed with Doxazosin mesylate GITS.

 Exclusion Criteria:

 -  Subjects with condition that are contraindicated with Doxazosin mesylate GITS based on
 the approved labeling in the Philippines.